Patients to benefit from new industry-NHS framework
A revised framework outlining ways in which the pharmaceutical industry
can co-operate with the NHS has been launched (PDF 4.1 MB).
The aim of the framework is to improve patient care, and it has been
agreed jointly by the Association of the British Pharmaceutical Industry
and all three bodies that represent NHS members and organisations: the
National Association of Primary Care, the NHS Alliance and the NHS Confederation.
“Production of this publication comes at a time when relationships
between the industry and the NHS have been under close scrutiny. Not
only does
the framework provide safeguards and reassurance that such relationships
are conducted to the highest possible ethical standards, but it also
spells out the clear advantages that such ventures can bring,” said
Richard Barker, director general of the ABPI.
The document includes a guide for partnerships and a checklist to assist
in the planning of joint initiatives. It also contains several case histories
that exemplify constructive ways in which the pharmaceutical industry
and the NHS have worked together on projects, resulting in benefits to
patients.
A copy of “NHS and pharmaceutical industry working together for
patients” can be obtained free from the ABPI, 12 Whitehall, London
SW1A 2DY (tel 020 7747 1446, e-mail publications@abpi.org.uk). |
The
Pharmaceutical Journal
Acrobat
Reader